Ligand Pharmaceuticals Incorporat.../ US53220K5048 /
23.05.2024 22:00:00 | Изменение -2.3700 | Объем сделки | Бид13:40:30 | Предложение13:40:30 | Максимум | Минимум |
---|---|---|---|---|---|---|
84.9100USD | -2.72% | 125,663 Оборот: 6.89 млн |
83.0000Величина цены спроса: 300 | 93.4500Величина цены предложения: 1,500 | 87.4750 | 83.1700 |
GlobeNewswire
14:00
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity wit...
GlobeNewswire
14:00
Weebit Nano and Efabless collaborate to enable easy, affordable prototyping of innovative SoC design...
GlobeNewswire
14:00
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common...
GlobeNewswire
14:00
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire
14:00
Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Sum...
GlobeNewswire
14:00
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenaden...
GlobeNewswire
14:00
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...
GlobeNewswire
13:30
BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in...
GlobeNewswire
13:30
Ollie’s Bargain Outlet Winning Bidder in Bankruptcy Auction to Acquire Eleven Former 99 Cents Only S...
GlobeNewswire
13:26
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Fourth Quarter 2023, Full Year 2023 and First Qu...
GlobeNewswire
13:05
Laguna Treatment Center Unveils New Name and Expanded Mission with Ribbon-Cutting Ceremony
GlobeNewswire
13:00
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница